The founding of TFSurvey wasn't an entrepreneurial moment. It was a breaking point.
The research team behind CGP Data Group had spent years commissioning B2B and healthcare studies through the industry's standard channels. But when a Fortune 500 pharmaceutical client's drug adoption study produced physician opinions that contradicted established clinical behavior, the question became unavoidable: whose opinions were we actually capturing?
The answer, after months of forensic analysis, was damning. A significant portion of "verified physicians" in that study were professional respondents — frequent survey-takers who had learned exactly which screening answers would qualify them for high-value healthcare surveys. Not doctors. Actors playing doctors, for the price of a survey incentive.
TFSurvey was built to fix this — not with better screeners, but with a fundamentally different verification architecture. We drew on CGP Data Group's data infrastructure expertise and partnered with CalibraSync — whose fraud detection had been built for financial services, where bad data carries real liability — to create a panel where quality was the only metric that mattered.